Introduction
Epilepsy is a chronic paroxysmal neurological disorder caused by the abnormal discharge of neurons. Approximately one-third of patients with epilepsy are refractory to medical treatment [1] . For patients with drug-resistant epilepsy, surgery is the only effective and established method. The success of epilepsy surgery depends directly on the precise identification of the surgically defined seizure focus, which is referred to as the epileptogenic zone (EZ); its removal is thought to render patients seizure-free [2] . Luders [3] defined the lesional zone as the ictal onset zone detected by video electroencephalography (EEG) and the irritative zone by inter-ictal EEG. The epileptogenic zone is thought to be located between the ictal onset zone and the irritative zone, but it has not been clearly delineated. This is probably because all previous investigations had different spatial and temporal resolutions. Furthermore, the different modalities used in various investigations may have provided different snapshots of epileptogenesis at different points in time [4] . Therefore, comprehensive high-quality neuroimaging techniques play an increasingly important role in delineating the epileptogenic region.
Structural magnetic resonance imaging (MRI) and EEG are essential diagnostic protocols to detect abnormalities in patients with epilepsy [5] . Structural MRI can identify cerebral lesions, such as hippocampal sclerosis, focal cortical dysplasia or brain tumours. Scalp EEG or video-EEG can monitor abnormal discharges of brain neurons. In most cases, patients with seizures can be diagnosed non-invasively, especially when EEG and MRI demonstrate concordant results [6, 7] . However, when the results from those non-invasive evaluations are negative or contradictory, the ultimate identification of a seizure focus becomes more difficult. Some patients require invasive intracranial EEG monitoring using depth electrodes, which is considered the gold standard in the Purpose: To assess the specific value of subtraction ictal and inter-ictal SPECT co-registered to MRI (SISCOM) in identifying the epileptogenic zone (EZ) and predicting postoperative outcomes in epileptic surgical patients. Method: A meta-analysis of studies published from January 1995 to June 2015 was conducted through a comprehensive literature search, and 11 studies were included. R software was first used to calculate a pooled positive rate, concordant rate and positive predictive value (PPV) for good outcomes. Stata software was then used to explore the relationship between SISCOM localization and surgical outcomes, including a subgroup analysis for extra-temporal lobe epilepsy. Results: The unweighted positive and concordant rates of SISCOM were 85.9% and 65.3%, respectively. In 142 MRI-negative patients, the SISCOM positive rate was 83.8%. The pooled PPV of 178 surgical patients with concordant SISCOM was 56%. In the meta-analysis of 275 surgical patients, the seizure-free odds ratio was 3.28-times higher in concordant than in non-concordant SISCOM patients [95%CI (1.90, 5.67)]. For extra-temporal lobe epilepsy, the seizure-free odds ratio was 2.44-times higher in concordant than in non-concordant SISCOM patients [95%CI (1.34, 4.43)]. Conclusion: Our data indicate that SISCOM has moderate sensitivity in localizing the epileptogenic zone and can provide complementary information when MRI is negative. Furthermore, SISCOM localization concordant with the gold standard demonstrates slightly higher predictive value for good surgical outcomes. Further research is required to explore the influence of SISCOM localization results in temporal lobe versus extra-temporal lobe epilepsy.
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localization of epileptic foci; however, this is associated with increased costs and risks of complications [8, 9] . Functional neuroimaging, such as single photon emission computed tomography (SPECT), has emerged as a promising technique for localizing the epileptogenic zone in the past few decades. It detects regional cerebral blood flow (rCBF) during epileptic seizures, which is associated with increased ictal neuronal activity [10] . During an ictal scan, the epileptic zone demonstrates increased hyperperfusion, while most epileptic foci demonstrate hypoperfusion during an interictal scan [11] . Subtraction of ictal and interictal SPECT co-registered to MRI (SISCOM) is an image processing technique that subtracts the interictal study from the ictal SPECT and co-registers it to an MR image; this has been shown to improve the sensitivity and specificity of seizure localization [12] . Ictal SPECT is performed immediately after clinical or EEG seizure onset, while interictal SPECT is performed when patients have been seizure-free for at least 24 h [12] . Several studies have assessed the practical clinical value of SISCOM in preoperative evaluation, comparing SISCOM with either ictal EEG, EEG-fMRI, surgical site or combined modalities [13] [14] [15] [16] . Several studies have also focused on the association between SISCOM localization results and postoperative outcomes. If SISCOM localization is concordant with the surgical resection site or other traditional techniques, postoperative outcomes are expected to be favourable [17] [18] [19] [20] . Several studies have suggested that SISCOM holds great clinical potential in the identification of seizure foci and that its localization results could be a valuable predictor of favourable seizure outcome; nevertheless, the sample sizes of individual existing studies have been insufficient. We therefore identified and combined all available literature data published from January 1995 to June 2015 to assess whether SISCOM has a practical localizing value in the presurgical evaluation of drugresistant epilepsy and helps to predict surgical outcome.
Methods

Data sources
A comprehensive literature search of ''PubMed'', ''Web of Science'' and ''Medline'' databases was performed. We searched the following key words alone and in combination: ''SISCOM'', ''subtraction ictal and interictal SPECT co-registered to MRI'', and ''epilepsy surgery''. References from all selected papers were further examined for additional relevant studies. All identified studies were considered and read in the full text version.
Study selection, classification and data gathering
The following inclusion criteria were defined: 1) Retrospective research; 2) Published from January 1995 to June 2015; 3) Published in English; 4) Reports of !10 patients of any age; 5) SISCOM as the evaluated method, with any other presurgical investigations blinded to each other and clinical data; 6) Used the gold standard as a reference, the surgical resection site or the presumed epileptogenic zone (PEZ, which was determined in consensus by taking into account video-EEG monitoring data as well as clinical and neuropsychological data); and 7) Surgical outcome reported using the Engel classification or directly comparable classification scheme.
The following exclusion criteria were defined:
1) Single case reports or reviews;
2) Meeting summary or full-text article unavailable; 3) Reports of <10 patients; 4) No gold standard as reference; and 5) No detailed information on each patient or the inability to extract such information.
Statistical analysis
All comparisons of SISCOM localization with the gold standard as well as the relationship between SISCOM localization and surgical outcomes were independently assessed by two reviewers. In case of disagreements between the reviewers, a consensus was reached after discussion.
The SISCOM findings were considered to be positive when SISCOM showed hyperperfusion in the ictal SPECT. The threshold for displayed hyperactivity was two standard deviations (SDs) above the mean.
The concordant rate of SISCOM was obtained by comparing the SISCOM results with the gold standard (surgical resection site or the presumed epileptogenic zone). The localization results of SISCOM were classified into two types: concordant SISCOM and non-concordant SISCOM. Concordance was defined as SISCOM's ability to precisely localize the epileptic zone (localized), or failing that, at least lateralize lesions to the suspected hemisphere (lateralized). Localized SISCOM was considered as perfusion changes restricted to a single region and concordant with the gold standard; lateralized SISCOM was used when perfusion changes were lateralized in the same hemisphere but not exactly concordant with the gold standard. Failure to visualize the epileptic focus or the presentation of an excessive number of lesions, making it impossible to identify a seizure focus, was defined as ''non-concordance'' (including non-localized and nonlateralized).
To clarify the relationship between SISCOM localization results and postoperative outcomes, concordant results were assessed in Engel I outcome patients (favourable outcome) versus Engel II-IV outcome patients (unfavourable outcome). The positive predictive value (PPV) for the outcome groups was a ratio calculated as PPV = a/(a + c). First, we used R Project for Statistical Computing (R software -a project initially written by Robert Gentleman and Ross Ihaka at Statistics Department of the University of Auckland; http://www. r-project.org) to calculate the weighted general positive rate, concordant rate and PPV of SISCOM. This was a meta-analysis of the individual rates, and normal distribution was a necessary condition. We entered the data in the software program and utilized the transformation methods provided by R software. Of the five transformation methods, logit transformation was selected because it had the least heterogeneity.
In the second step, we utilized Data Analysis and Statistical Software (Stata software -a project developed at American Computer Resource Centre; http://www.stata.com/) to perform a meta-analysis; we employed an odds ratio of concordant versus non-concordant SISCOM results for the Engel I outcome. The single odds ratio (OR) of each study was calculated as OR = ad/bc. The pooled odds ratio was calculated to assess the relationship between SISCOM localization and postoperative outcomes.
Finally, all studies were separated into three subgroups: those focused on temporal lobe epilepsy, extra-temporal lobe epilepsy and both temporal and extra-temporal lobe epilepsy. To investigate the differences in SISCOM localization in temporal lobe epilepsy and extra-temporal lobe epilepsy, we calculated the pooled odds ratio of concordant versus non-concordant SISCOM results for the Engel I outcome in temporal lobe and extratemporal lobe epilepsy.
The heterogeneity of each meta-analysis was assessed by a visual analysis of the forest plot and quantitative analysis of I 2 and Q values. If there was heterogeneity, a random effects model was used in each category; otherwise, a fixed effects model was used.
Egger's regression test and Begg's adjusted rank correlation test were used to verify the symmetry of the funnel plot to evaluate the publication bias.
Results
Evidence base
The literature search yielded 360 citations, 27 of which were potentially eligible based on the theme and abstract and were independently reviewed in full text by two reviewers. Of these, 16 articles were excluded, and the remaining 11 articles were included. Of the 11 included articles, 1 study investigated only temporal lobe epilepsy, 4 studies investigated only extra-temporal lobe epilepsy and 6 studies investigated both temporal and extratemporal lobe epilepsy. The search strategy is illustrated in Fig. 1 . The characteristics of the 11 articles and overall correlated statistics for SISCOM are listed in Tables 1 and 2 , respectively.
Meta-analysis of positive rate
The meta-analysis included 11 studies involving 320 patients, among which 275 patients were SISCOM-positive. There was certain heterogeneity (I 2 = 45. 6%, Q = 0.2846, p = 0.0491) in this meta-analysis. The p value of the Egger test was 0.0001605 (p < 0.05), which indicated that the funnel plot was asymmetric and that there was publication bias (Supplementary Fig. 1 and Supplementary Table 1) . As a result, we summarized the statistics in an unweighted manner. The unweighted positive rate of SISCOM was 85.9% (275/320). There were 142 MRI-negative patients among the total of 320 patients; among these, there were 119 SISCOM-positive patients. As a result, the SISCOM positive rate in MRI-negative patients was 83.8% (119/142).
Meta-analysis of concordant rate
Among the 320 patients, 71 patients were compared using PEZ, and 240 patients were compared using the surgical site (9 patients were excluded due to the lack of surgery or comparison information). A total of 203 patients had results concordant with the gold standard. From the single sample rate of meta-analysis in these 311 patients, there was also certain heterogeneity (I 2 = 61.0%, Q = 0.2938, p = 0.0042). The p value of the Egger test was 0.0042 (p < 0.05), which indicated that the funnel plot was asymmetric and that there was publication bias (Supplementary Fig. 2 and Supplementary Table 1) . Consequently, the unweighted concordant rate of SISCOM was 65.3% (203/311).
Meta-analysis of PPV of 178 surgical patients with concordant localization
There were 275 patients undergoing epilepsy surgery; 178 had SISCOM localizations concordant with the gold standard, and 100 had a favourable outcome. I 2 and Q (tau-squared) as measures of heterogeneity were 23.7% and 0.0881, respectively. The results rejected the null hypothesis of heterogeneity (p = 0.2173 > 0.10); thus, we used the fixed effects model. The PPV for surgery patients was 56%, and the 95% credibility interval was 49-64% ( Fig. 2) , which suggests that 56% of patients with concordant SISCOM may have favourable surgical outcomes. The p value of the Egger test was 0.252 (p > 0.05); therefore, we could assume that the funnel plot was generally symmetric (Supplementary Table 1 ).
Meta-analysis of 275 surgical patients
To identify the relationship between SISCOM localization and surgical outcomes, Stata software was used for a meta-analysis. The meta-analysis included 11 subgroups involving 178 patients with concordant SISCOM cases and 97 patients with nonconcordant SISCOM cases. I 2 and Q (chi-squared) as measures of heterogeneity were 16.6% and 12.00, respectively. The results rejected the null hypothesis of heterogeneity (p = 0.285 > 0.10); thus, a fixed effects model was selected. The seizure-free odds ratio in concordant SISCOM patients was 3.28-times higher than that in non-concordant SISCOM patients, and its 95% credibility interval was 1.90-5.67 (Fig. 3) . A funnel plot was used to roughly estimate publication bias, and, as shown in Figs. 4 and 5, it was generally symmetrical. Egger's regression test and Begg's adjusted rank correlation test were then applied to verify the symmetry of the funnel plot. As shown in Supplementary Figs. 3, 4 , Tables 3 and 4 , the results of Egger's test (t À0.67, p = 0.517 > 0.10) and Begg's test (z = 1.09, P 0.276 > 0.10) were not statistically significant. As a consequence, we can assume that the funnel plot is generally symmetrical and that the publication bias was well controlled.
Among the 275 surgical patients, there were 209 extratemporal lobe epilepsy patients and 66 temporal lobe epilepsy patients. Because the numbers of temporal lobe epilepsy patients were small, we focused on extra-temporal lobe epilepsy patients.
The meta-analysis of extra-temporal lobe epilepsy patients For patients with extratemporal lobe epilepsy, the seizure-free odds ratio in concordant SISCOM was 2.44-times higher than that in non-concordant SISCOM; its 95% credibility interval was 1.34-4.43 (Fig. 4) . The funnel plot was also used to roughly estimate publication bias ( Supplementary Fig. 5 (Tables 3 and 4 ). The publication bias was considered well controlled.
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Discussion
Single-photon emission computed tomography (SPECT) can detect changes in cerebral blood flow during epileptic seizures; it is considered a complementary diagnostic method in the localization of seizure focus when non-invasive MRI and EEG are negative. Subtraction of ictal and interictal SPECT co-registered to MRI (SISCOM) is a computer-aided method that helps to improve the sensitivity and specificity of preoperative epileptic foci localization [12] . We conducted this meta-analysis because the individual studies evaluating SISCOM typically only include a small number of patients. Our aim was to assess the practical value of SISCOM in the preoperative evaluation for identifying the epileptic focus in patients undergoing epilepsy surgery.
The positive and concordant rates of SISCOM computed by R software showed certain heterogeneity, and the Egger's test suggested that there was publication bias in the included studies. Unfortunately, it was only possible to summarize these two statistics in an unweighted manner. The unweighted positive and concordant rates of SISCOM were 85.9% and 65.3%, respectively. The variation in the results may have occurred for several reasons. First, we only included studies in which SISCOM results were compared with the gold standard, which may have underestimated the positive rate of SISCOM. Moreover, the first three articles were from the same organization, and there was probably some overlapping data. Over the past few years, many researchers have compared SISCOM results with other techniques and found that SISCOM has relatively high sensitivity and consistency. So et al. [21] used MRI, ictal EEG and SISCOM to evaluate 51 drugresistant epilepsy patients and found that the sensitivity of SISCOM was 88%, which compared very favourably with the sensitivity of 50% for MRI and 64% for intracranial EEG. Dupont et al. [22] evaluated the relationship between SISCOM and MRI-visible focal dysplastic lesions (FDL) and found that 93% (14/15) showed SISCOM hyperperfusion overlapping with FDL. In MRI-negative cases, the identification of seizure focus seems to be more difficult. SISCOM can be deemed as a complementary diagnostic method. In our study, there were 142 MRI-negative patients, among which 119 patients were SISCOM-positive (83.8%). As a consequence, SISCOM shows a slightly high sensitivity in seizure localization and can be used as a supplementary tool, especially for MRI-negative patients.
Many scholars have focused on the predictive value of SISCOM for postoperative seizure-free outcomes. They compared SISCOM results with other conventional measures, such as intracranial EEG, PET and surgical resection site [14, 15] . Von Oertzen et al. [23] evaluated the prospective use of SISCOM in drug-refractory epilepsy. SISCOM results were compared with the gold standard for seizure onset detection, and the authors found that SISCOM was concordant with the surgery site in 82% of patients; after 2 years of follow-up, 84.6% (22/26) of patients showed favourable outcomes. Ana 2008  16  17  13  17  2  10  12  Bell 2009  33  40  27  33  18  27  33  Seo 2011  14  14  12  14  6  12  14  Schneider 2013  14  14  13  14  6  13  14  Kudr 2013  13  14  13  14  5  13  14  Perissinotti 2014  41  54  38  54  7  16  23  Kargiotis 2014  11  13  7  11  5  7  11  Cho 2015  75  75  39  75  25  39  75  Total  275  320  203  311  100  178  275   Table 1 Characteristics of the included studies (n = 11 Valenti et al. [24] retrospectively evaluated the usefulness of SISCOM in temporal lobe epilepsy related to dysembryoplastic neuroepithelial tumours and concluded that concordance between SISCOM results, electro-clinical data and MRI was predictive of a good postoperative outcome. Compared with other functional techniques, such as FDG-PET, SISCOM also had a higher predictive value for good outcomes (odds ratio 9.1 vs. 7.1) [25] . In our study, we first calculated a pooled PPV to assess the proportion of patients with good outcomes in all patients with concordance results. The positive predictive value of seizure-free patients (Engel I) was 56% [95%CI (49-64%)]. In the meta-analysis of 275 surgical patients, 178 patients had a favourable outcome (Engel I), and 97 patients had an unfavourable outcome (Engel II-IV). The seizure-free rate in concordant SISCOM patients was 3.28-times higher than that in non-concordant SISCOM patients [p = 0.285, I 2 = 12.00%, 95%CI [ ( F i g . _ 2 ) T D $ F I G ] reliable. This result and those of previous studies have demonstrated that the resection of the epileptogenic zone delineated by SISCOM is a significant determinant of a favourable surgical outcome.
Earlier studies found that SISCOM localization sensitivity was better than 90% in temporal lobe seizures but much lower in extratemporal lobe epilepsies [26, 27] ; however, recent studies have found that SISCOM has high localizing and predictive value for good outcomes in extra-temporal lobe epilepsy. Kim et al. [28] investigated the effect of multimodal techniques, including MRI, PET and SISCOM, on the surgical outcomes of 42 paediatric patients. SISCOM showed a concordance rate of 100% and precise localization rate of 66.7% in temporal cases. For extra-temporal cases, the concordance rate was 92.3%, and the localization rate was 84.6%. PET showed concordance in 95.5% of temporal and 68.4% of extra-temporal lesions, with localization in 72.7% of temporal lesions. Bouilleret et al. [15] established the concordance rates of PET and SISCOM region by region; they found that PET abnormalities were more frequent than SISCOM changes in the mesial temporal region, and SISCOM abnormalities were more widespread in the extra-temporal region. In the 11 articles included in our study, there were 66 patients with temporal lobe epilepsy and 209 patients with extra-temporal lobe epilepsy. We concentrated on the 209 extra-temporal lobe epilepsy patients and The tracer injection time of the ictal SPECT scan is crucial for analysing SISCOM results. A previous meta-analysis of SPECT derived the sensitivity and specificity of interictal, postictal and ictal rCBF changes to identify the seizure focus in drug-resistant epilepsy. Sensitivities for SPECT localization compared with standard diagnostic evaluation and surgical outcome were 0.44 (interictal), 0.75 (postictal), 0.97 (ictal) and 0.43 (interictal), 0.77 (postictal) and 1.00 (ictal), respectively [11] . Tracer injection at the time of seizure improved the sensitivity and specificity of seizure localization. In our study, only 13 patients had postictal scans. Unfortunately, we did not have detailed information for each patient; thus, we were unable to perform the meta-analysis excluding them. However, most of the data were gathered during the ictal SPECT scan, and our conclusions are therefore still compelling.
There are several limitations in this meta-analysis. First, the studies included in our analysis were retrospective. The clinical decision to proceed with surgery depends on many factors (e.g., presurgical evaluation findings or patient preference), and the postoperative outcome depends on the quality of the clinical decision as well as the quality of the surgery itself (e.g., extent of resection). Furthermore, SISCOM localization results may influence the surgical decision. As a result, the concordant rate and PPV may be subject to bias. Further prospective studies focused on SISCOM will be necessary. Second, we focused only on the localization results; other parameters, such as seizure frequency and seizure type, may also affect SISCOM results. Moreover, we did not distinguish ictal from postictal SPECT data, and further studies should concentrate on the other factors that may influence SISCOM results. In addition, we did not take age into consideration, which could have had an impact on the localization results. Finally, the number of patients with temporal lobe epilepsy was too small to have any statistical significance. As a result, the subgroup analysis was not sufficient, and further data will need to be collected.
Conclusion
The SISCOM technique is feasible and reliable for patients with epilepsy, especially those with non-lesion and extra-temporal lobe epilepsy. However, we cannot currently conclude that SISCOM is the only appropriate investigation and can replace invasive techniques; it is only one of several optional investigations utilized during presurgical evaluation. SISCOM could provide more complementary information together with other conventional measurements. Furthermore, SISCOM evaluation has a moderate PPV for good postoperative outcomes. This is the first meta-analysis of SISCOM, and our data further confirm that the localizing results of SISCOM could be a valuable indicator for seizure-free outcomes. As a result, SISCOM provides an accurate alternative to other traditional investigations and should be considered an important tool in the preoperative assessment for epilepsy surgery. 
